12 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

EDGEWISE CERAMIC BRACKETS, ROTH CERAMIC BRACKETS

FDA 510(k)
FDA Class 2 ·Dental

Oticon

FDA UDI
Oticon A/S·05707131255686·SENSEI, BTE 312 WL 75 CNB

MODIFICATION TO SMART CONTROL NITINOL STENT TRANSHEPATIC BILIARY SYSTEM

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

PARIE TENE PROGRIP MESH

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·May 28, 2025

BD PHASEAL PROTECTOR P50J

FDA Adverse Event
Malfunction ·BECTON DICKINSON, S.A.·Product code ONB·July 7, 2023

BENEVIEW MONITOR

FDA Adverse Event
Malfunction ·MINDRAY BIOMEDICAL ELECTRONICS CO.·Product code MHX·May 23, 2013

PRIMUS GREAT TOE IMPLANT WITH GROMMETS SIZE 20

FDA Adverse Event
TORNIER INC.·Product code KWH·August 19, 2014

VITA 2

FDA Adverse Event
Injury ·MEDTRONIC S.A.·Product code NVZ·June 16, 2011

Alaris Syringe Pump, Model No. 8110. Delivers fluids. Expansion of Affected Units: BOM Housing Assembly Service, Part No. 49000226, and Lower Housing/Carriage Block Assembly, Part No. 148188-100.

FDA Enforcement
Class I ·Terminated·CareFusion 303, Inc.·August 26, 2015

CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024

Ultraview SL Command Modules, Model 91496, with the Masimo SpO2 PCBA, PN: 010-1636-02. The Spacelabs Multi-parameter Module is intended for use with the Patient Care Management System (PCMS) to acquire, monitor, and process various clinical parameters from an adult or neonate/infant populations in any type of clinical environment other than home use.

FDA Enforcement
Class II ·Terminated·Spacelabs Healthcare Inc·May 13, 2015